Abstract
A 50-year-old male who developed subclavian vein thrombosis following insertion of a demand pacemaker was treated with a short period of high-dose recombinant tissue plasminogen activator (100 mg over 3 hours). Total thrombolysis was achieved without complications.
Get full access to this article
View all access options for this article.
References
1.
Turpie
AGG
. Thrombolytic therapy in venous thrombosis . In:
Agnelli
G
, editor. Thrombolysis yearbook-1994 . Amsterdam : Excerpta Medica , 1994 :137 –47 .
2.
Marder
VJ
Bell
WR
. Fibrinolytic therapy . In:
Colman
RW
Hirsh
J
Marder
VJ
Salzman
EW
, editors. Hemostasis and thrombosis . Philadelphia : Lippincott , 1982 ;1393 –437 .
3.
Kalikar
N
Flanc
C
Howe
CT
Treatment of deep vein thrombosis: a trial of heparin, streptokinase and arvin . Br Med J
1969 ; 1 : 806 –10 .
4.
Johansson
L
Nylander
GM
Hedner
U
Nilsson
IM
. Comparison of streptokinase with heparin: late results in the treatment of deep venous thrombosis . Acta Med Scand
1979 ; 206 : 93 –8 .
5.
Weimar
W
Stibbe
J
Van Seyen
AJ
Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue type) plasminogen activator . Lancet
1981 ; 2 : 1018 –20 .
6.
Marder
VJ
Brenner
B
Tottermans
Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis . J Lab Clin Med
1992 ; 119 : 485 –95 .
7.
AbuRahman
AF
Short
YS
White
JF
Boland
JP
. Treatment alternatives for axillary subclavian vein thrombosis: long-term follow-up . Cardiovasc Surg
1996 ; 4 : 783 –7 .